FDA Inspection
Vistin Pharma AS avd Kragero FikkjebakkeVistin Pharma AS avd Kragero Fikkjebakke – FDA Inspection, May 24, 2019
Record Details
This FDA Inspection record concerns Vistin Pharma AS avd Kragero Fikkjebakke, with an inspection on May 24, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f6cd5fdd-c758-4c11-be0c-073d10bf76d8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096538
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Vistin Pharma AS avd Kragero Fikkjebakke
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 31, 2025 | Not classified | Office of Inspections and Investigations | |
| July 4, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Vistin Pharma AS avd Kragero Fikkjebakke
- FDA Inspection 1262011 - 2025-01-31
- FDA Inspection 892560 - 2014-07-04
- FDA Inspection 731804 - 2011-06-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.